NanoViricides Inc (NNVC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $1.00
• Market Cap: $22.22M
• EPS: $-0.50
• 52-Week High: $2.23
• 52-Week Low: $0.85

Market Sentiment

NanoViricides Inc currently has a Bullish sentiment score of 0.46.

About NanoViricides Inc

NanoViricides Inc. (NNVC) is an innovative nanobiopharmaceutical firm headquartered in Shelton, Connecticut, dedicated to the research and development of cutting-edge antiviral therapies. Leveraging its proprietary nanomedicine platform, the company creates targeted treatments that address various viral infections and significant unmet medical needs within the healthcare sector. With a robust clinical and preclinical pipeline, NanoViricides is well-positioned for substantial growth in the evo...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NanoViricides Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NNVC pay dividends?

NanoViricides Inc (NNVC) does not currently pay a regular dividend.

What is NNVC's market cap?

NanoViricides Inc (NNVC) has a market capitalization of $22.22M with a current stock price of $1.00.